ANIX
Anixa Biosciences Inc
Anixa Biosciences Inc (ANIX) has 3 SEC Form 4 filings (3 transaction rows) in the rolling window, disclosed by 2 distinct insiders. Most recent filing: Jul 16, 2026.
- Industry:Biotechnology
- CEO:Amit Kumar
- Employees:5
- HQ:San Jose, CA, US
- IPO:1983-10-07
Insider Buying
$32K
reported purchases (SEC code P)
Insider Selling
$0
reported sales (SEC code S)
Unique Insiders
2
in the rolling window
Market Cap
$113.0M
latest known value
| Source | ||||||
|---|---|---|---|---|---|---|
| Director | Purchase | 2,797 | $9K | Jul 16 | SEC ↗ | |
KUMAR AMITFirst filing | Chief Executive Officer | Purchase | 5,000 | $15K | Jul 13 | SEC ↗ |
Titterton Lewis H jrFirst filing | Director | Purchase | 2,836 | $7K | Jun 17 | SEC ↗ |
Related companies
Anixa Biosciences Inc is in the Healthcare sector.